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Summary The in vitro thymidine labelling indices (TLI) of 58 human lung tumours were assessed using
autoradiography. The labelling technique involved incubation of 1 mm3 tumour fragments with 3H-thymidine
(5 1CimlP ) under conditions of hyperbaric oxygenation at a pressure of 3 atmospheres. Only a rim of
labelling was achieved along the edges of fragments and the depth of this rim varied from tumour to tumour.
A technique for counting TLIs was therefore devised to take this into account. In general, those tumours
showing low TLI values of <5.0% showed a greater depth of labelling. The common malignant tumours of
the bronchus showed a wide range of values (2.2-30.4%) though the adenocarcinomata had a lower average
value than the other groups. With the squamous carcinomata a relationship with differentiation was shown.
The mean value for small cell carcinomata (16.9%)-a highly aggressive tumour-was no higher than for the
other groups. The low grade malignant tumours showed TLIs of <3.0% and these values correlate with their
less aggressive clinical behaviour. Labelling of stromal cells and inflammatory cells varied greatly from tumour
to tumour; however, no correlation was found with the TLIs of tumour cells.
In any proliferating cell population S-phase cells
can be radioactively labelled by brief exposure to
tritiated (3H-methyl) thymidine ([3H]dT) which is
incorporated into their duplicating DNA. The
thymidine labelling index (TLI) of this population
can then be measured using autoradiography as a
means of assessing cell proliferation (Cleaver, 1967).
The study of tumour cell proliferation is valuable
since this gives some information on tumour
growth rates; this is of particular interest in human
lung neoplasia where a parallel study of actual
tumour growth on chest X-ray films is possible
(Kerr et al., in preparation).
Tumour labelling with [3H]dT in vivo has both
ethical and technical drawbacks (Tubiana &
Malaise, 1976) and so an in vitro method was
sought. Methods using cell suspensions prepared
from solid tumours have been used (Coons et al.,
1966; Livingston et al., 1974; Nordenskj6ld et al.,
1974; Sklarew et al., 1977). However, labelling
small tissue fragments makes tumour cell
identification easier, maintains intercellular
relationships with the tissue and reduces the
amount of tissue handling and trauma. Such a
technique also allows thymidine labelling in other
cell populations within a tumour (stromal cells,
inflammatory infiltrate) to be examined.
There are problems in attempting to label cells in
fragments of solid tumours in vitro, in particular
failure to achieve S-phase cell labelling throughout
the fragments used (Johnson & Bond, 1961;
Wolberg & Brown, 1962; Titus & Shorter, 1965;
Lieb & Lisco, 1966). In this investigation involving
a study of 58 human lung tumours we have used an
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incubation technique involving simple hyperbaric
oxygenation at a pressure of 3 atmospheres which
has been claimed to give good labelling of breast
tumour fragments to a depth of 500pm (Fabrikant
et al., 1969; Meyer & Bauer, 1975).
The TLIs obtained have been compared with the
tumour cell type diagnosed using the modification
of the Working Party on Lung Cancer (WP-L) of
the WHO lung tumour classification (Matthews,
1976).
Materials and methods
Lung tumours
Fifty-eight human lung tumours (53 primary
tumours and 5 secondary pulmonary deposits)
removed at thoracotomy in the Thoracic Unit, City
Hospital, Edinburgh were studied. A representative
slice 2mm thick from the cut surface of the tumour
was taken as soon as possible after surgical
resection and transported to the laboratory in
Eagle's MEM (Minimum Essential Medium, Gibco-
Biocult) in a sterile universal container at 40C on
ice. A parallel representative slice was taken for
histological examination.
Classification oflung tumours
The tumours were classified histologically using
both the material taken for purely diagnostic
purposes and the representative slice taken at the
time of culture. The 4 major histological groups
(squamous, large cell undifferentiated, small cell
undifferentiated and adeno-carcinoma) were
classified according to the criteria of the WP-L
classification (Matthews, 1976) or in the case of the
remaining tumours, according to the WHO
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classification. Of the 58 tumours there were 26
squamous carcinomata, 10 large cell
undifferentiated carcinomata (5 with and 5 without
stratification), 3 small cell undifferentiated
carcinomata, 7 adenocarcinomata, 4 carcinoids, 1
adenoid cystic carcinoma, 1 mucoepidermoid, 1
primary clear cell carcinoma, 3 secondary renal
carcinomata, and 2 secondary undifferentiated
carcinomata.
Tumour labelling in vitro
The tumour tissue was chopped into fragments of
approximately 1 mm3 in size with a scalpel blade in
a plastic petri dish containing fresh medium.
Approximately 10 fragments were transferred into
7ml capacity Bijou bottles (with metal screw cap
and rubber gasket) containing 5ml medium with
HEPES buffer, 10% heat-inactivated foetal bovine
serum (HIFBS-Flow Laboratories) and 5pCiml-'
tritiated (3H-methyl) thymidine ([3H]dT; Sp. Act.
40CimM-l-Radiochemical Centre, Amersham).
For each tumour, bijou bottles were set up in
duplicate or triplicate.
Hyperbaric oxygenation at a pressure of 3
atmospheres was attained above the fluid phase in
the sealed bottles by gas injection through an off-
centre 1.3 mm diameter hole in the metal cap
(through the rubber gasket which reseals after
injection) using a plastic syringe and 25G bore
needle. Six ml of95%0 2/5% CO2 (B.O.C. Ltd.) was
injected into the 2ml of air remaining in the bijou
bottles. Each bottle was then inverted several times
by hand and incubated for 1 h at 37°C in a shaking
water bath (160 strokes min-1). After incubation
the bottles were depressurised using a syringe and
needle and this confirmed persisting hyperbaric
oxygenation in all cases. Tissue fragments were then
washed x 3 in ice-cold phosphate-buffered saline,
fixed in Bouin's fluid, dehydrated and embedded in
paraffin wax. Three pm thick tissue sections were
cut and mounted on glass slides; the first 200pm of
tissue sections were discarded to avoid tangential
sections cut through the edges of the incubated
fragments.
Autoradiography
Slides were dipped in liquid emulsion (Ilford K5,
diluted 2:1 with 1% glycerol) and after exposure for
3-4 weeks at 4°C wete developed in Kodak D19
developer. Sections were then stained with Harris's
haematoxylin and eosin.
Assessment of thymidine labelling index (TLI) and
mitotic index (MI)
A repeatable and valid method of assessment of
TLI had to be devised to take account of labelling
only in the outer rim of the tissue fragments and
the variability of this rim from case to case. In the
earlier cases the pattern of labelling along fragment
edges was first assessed by taking a crossed, ruled
eye piece graticule and measuring the distance
between each labelled cell nucleus and the nearest
point on the fragment edge to this cell. A histogram
was then constructed with 10pm deep domains, the
range comprising the number of cells in each
domain and this indicated the depth in the tissues
at which cell labelling was becoming less than
maximally efficient. It was found that a depth of
rim from which a valid TLI could always be
obtained was 70-80pm and hence this was used as
a standard. For TLI assessment, a squared eye piece
graticule (measuring 75 x 75pm at x 1200
magnification under oil immersion) was used to
measure the number of labelled tumour cells in all
consecutive adjacent fields comprising a fragment
edge which contained labelled cells. Completely
unlabelled edges were not included as it was
assumed that these had either been touching the
base of the bijou bottle or in contact with adjacent
fragment edges during incubation. Where possible,
depending on tumour cell availability, a total of 2-
10 x 103 cells per case were counted. In some cases,
particuilarly those with a very low TLI, there was
no decrease in labelling until - 300pm; thus in
order to obtain sufficient numbers of labelled
tumour cell nuclei, a labelled rim of .300pm in
depth could be used for counting those cases.
To enable comparisons of the labelling rim from
case to case, histograms of the percentage of
labelled cells versus the depth from the fragment
edge were constructed for 23 cases and a depth
(pm) was calculated superficial to which an
arbitrary 70% of all labelled tumour cells would be
found. We have referred to this figure as the "D70"
of the tumour. Only solid tumours showing good
even distribution of tumour cells along the edges
and throughout the fragment could be included in
this assessment.
In 28 cases (the latter ones collected), a mitotic
index (MI) was measured using 1pm thick araldite-
embedded tissue sections of non-labelled tumour
fragments. For araldite sections, a small
representative piece of tumour was fixed as soon as
possible after removal from the lung in 3%
gluteraldehyde (TAAB) in 0.2M sodium cacodylate
buffer (BDH) at pH 7 for 24h. After post-fixation in
1% OS04 in 0.2 M sodium cacodylate buffer the
tissue was embedded in araldite. One micron
sections were cut and stained with toluidene blue.
From 2-17 x 103 cells were counted per case
depending on availability of the tumour cells in
sections.THYMIDINE LABELLING OF PULMONARY NEOPLASMS 247
Results
Histograms
Despite suggestions that hyperbaric oxygenation at
3 atmospheres pressure would produce adequate
labelling up to 500pm depth, i.e. label S-phase cells
throughout 1 mm3 fragments (Meyer & Connor,
1977), most of our tumour fragments showed only a
rim of labelling with a marked fall-off of label
towards the centre of the fragment. The thickness of
this rim and pattern of fall-off varied from case to
case. This is illustrated in figures la, b which show
histograms of the percentage of labelled cells versus
distance from the fragment edge for a narrow and
wide rim respectively. For the narrow rim which
was obtained with a poorly-differentiated squamous
carcinoma, the fall-off in the number of labelled
cells occurred after - 140pm (Figure la). For the
wide rim, obtained with the adenoid cystic
carcinoma, the fall-off occurred after - 300pm
(Figure lb).
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Thymidine labelling indices (TLI) ofdiferent tumour
cell types
Figure 2 shows the TLIs as a percentage of tumour
cells for the common malignant tumours of the
bronchus. Each histological group shows a wide
range of values and the bars represent the means.
For the squamous carcinomata, the mean TLI is
much lower in the well-differentiated category (5.9%)
compared with the moderately well-differentiated
and poorly-differentiated categories (14.5 and 13.0%
respectively). The large cell undifferentiated group
showing stratification has the highest mean TLI of
all histological types in our series (21.0%), i.e. there
is a difference of 15.1% between the extreme ends of
the differentiation scale (P<0.001, Mann-Whitney
U test).
The large cell undifferentiated series (which show
no stratification) and small cell undifferentiated
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Figure 1 Histograms of the percentage of [3H] dT-
labelled tumour cells versus distance in ,um from the
fragment edge for (a) a poorly differentiated squamous
carcinoma (240 labelled cells counted in total), (b) an
adenoid cystic carcinoma (67 labelled cells counted in
total). The arrow indicates the depth up to which a
valid thymidine labelling index may be obtained, i.e.
the depth after which labelling falls off and becomes
less than maximally efficient (140pm for (a) and
300pm for (b)).
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Histological group
Figure 2 [3H] dT labelling indices (TLI) for the
different histological types of carcinoma of the
bronchus (squamous carcinoma, large cell
undifferentiated carcinoma, small cell undifferentiated
carcinoma adenocarcinoma). The large cell
undifferentiated group has been divided into these with
stratification (+S) and those without (-S). Each dot
represents one case. Each bar represents the mean
value of TLI for the histological group. WD, well
differentiated; MWD, moderately well differentiated;
PDD, poorly differentiated.
9
0
.
100 300 400 200248 K.M. KERR, A.M.G. ROBERTSON & D. LAMB
category (or oat cell carcinomata) both show a wide
range of TLIs, but both show fairly high means of
15.0% and 16.9% respectively.
No apparent difference is noted between the
differentiation categories of the adenocarcinomata.
The series is small, but both the well-differentiated
and poorly-differentiated categories show a fairly
low mean TLI (5.2% and 7.9% respectively).
The less common histological lung tumour
categories (carcinoids, adenoid cystic and
mucoepidermoid carcinomata) of which all are low
grade malignant tumours showed very low TLIs of
<1.5%. Primary clear cell carcinoma is extremely
rare and usually included in the large cell
undifferentiated category (Matthews, 1976);
however, the TLI (2.8%) was much lower than the
values obtained in that group. Three secondary
renal carcinomata also showed a low mean TLI
value of 2.2% By contrast, 2 secondary
undifferentiated tumours, both of which showed
high TLIs (mean, 22.2%) originated from the same
lobe of a male patient with a primary cancer of an
as yet unknown site.
Mitotic index (MI) values
For a range of tumours the MI was assessed to
ensure that a low TLI was not due to poor
incubation conditions and consequent poor uptake
of the [3H]dT into the fragment. The MI values
were found to increase in proportion with an
increase in TLI for the 28 cases assessed (Figure 3).
Comparison ofdepth oflabelling
The labelled rim of cells varied widely between
cases, many of the tumours of low malignancy and
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Figure 3 Relationship between the [3H] dT labelling
index (TLI) and mitotic index (MI). Each dot
represents one case. For the regression line (y=ax), the
correlation coefficient between y and x is 0.66
(P<0.001).
low TLI having a much deeper rim. The thickness
of each rim was assessed by measuring the D70
values, i.e. the depth superficial to which an
arbitrary 70% of all labelled cells in that population
would be found. An inverse relationship between
the TLI and depth of labelling is apparent (Figure
4) and may be exponential in character. In general,
tumours with TLI values of <5.0% showed a
greater depth of labelling.
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Figure 4 Relationship between the [3H] dT labelling
index (TLI) and the depth of labelling. D70 is the
depth superficial to which 70% of labelled tumour cells
are found (see Materials and Methods). Each dot
represents one tumour case. For the high TLIs, 200
cells were assessed; however, for the low grade
malignant tumours where the TLI was < 1.5%,
obviously very few. cells (<50) were available for
assessment. The line fitted to the points is that for an
exponential relationship (y=axb); the correlation
coefficient between y and x is 0.88 (P<0.001).
TLI ofstromal cells and inflammatory cell infiltrate
The cellularity of the stroma and the degree of
inflammatory infiltrate varied widely from tumour
to tumour. This made comparative quantitative TLI
assessments on such cell populations difficult.
The TLIs of stromal cells and the inflammatory
infiltrate both varied from 0-3.5% for different
tumours, though most cases showed a very low
degree of labelling; there was also some variation in
the TLIs of these components in different areas of
the same tumour.
No relationship was found between the TLI of
stromal and inflammatory cells and the TLI ofTHYMIDINE LABELLING OF PULMONARY NEOPLASMS 249
tumour cells. However, it was of some interest that
labelling of stromal and inflammatory cells occurred
to depths of at least twice that seen for the tumour
cells, i.e. D70 values differed for different cell
populations within the same tumour fragments.
Discussion
Thymidine labelling in tumours
For the squamous carcinomata series the
moderately well-differentiated and poorly-
differentiated categories show higher mean TLIs
(14.5 and 13.0% respectively) than the well-
differentiated category (5.9%) and this agrees with
the presence of larger areas of keratinisation in the
well-differentiated tumours where cells are no
longer dividing as would be expected (Malaise et al.,
1973). The large cell undifferentiated group showing
stratification is considered by some pathologists to
be the least differentiated group of squamous
carcinomata and is included under that heading in
the WP-L classification (Matthews, 1976). These
cases have a higher mean TLI than the poorly-
differentiated squamous carcinomata, and include
the highest labelled tumour in our series at 30.4%.
Terz et al., (1971) published a TLI of 30.8% in an in
vivo labelled ulcerating skin metastasis from a
primary epidermoid carcinoma of the lung. Muggia
(1973), Livingston et al., (1974), Hainau et al., (1977)
and Strauss & Moran (1977) have also performed
[3H]dT labelling studies on series on series of lung
tumours found mean TLI values for squamous
carcinomata of 2.5, 3.4, 7.5 and 8.4% respectively.
Only Hainau et al. (1977) subdivided their
squamous carcinomata into subgroups based on
their degree of differentiation, and found that highly
differentiated tumours (showing abundant
keratinisation) had a median TLI value of 5.8% and
dedifferentiated tumours a median value of 9.8%.
The overall mean value in our series for all groups
of squamous carcinoma and the large cell
undifferentiated carcinoma group showing
stratification is 13.6% which is considerably higher
than the results of the above authors' work. In
addition Muggia (1973) and Hainau et al., (1977)
both have in their range of values very low TLIs
(<1%). We consider it striking that, in our results,
while the majority of cases lie between 5-10% no
case of squamous carcinoma has a TLI value of
<5%.
The large cell and small cell undifferentiated
series show a wide range of TLIs with moderately
high mean values of 15.0 and 16.9% respectively.
However, the small cell undifferentiated
carcinomata, despite their rapid clinical progression
in vivo do not show the highest TLI in our series.
Muggia (1973), Livingston et al. (1974) and Hainau
et al. (1977) showed higher mean values for their
small cell carcinomata than for their squamous
carcinoma series. However, though Hainau et al.
(1977) reported a mean of 11% for the small
carcinomata, their cases ranged widely from 1.9% to
28.0%. Their low values may represent problems of
technique or the occasional difficulties in
differentiating between some carcinoid tumours and
small cell carcinomata.
The discrepancy observed between a relatively
low TLI and rapid in vivo growth is less of a
paradox than it at first appears since many other
factors besides tumour cell proliferation determine
their actual growth rate.
Few primary adenocarcinomata were examined in
this series and no difference was observed between
the well-differentiated and poorly-differentiated
categories. The low TLIs (5.2 and 7.9%
respectively), are in-keeping with other published
reports where Muggia (1973), Livingston et al.
(1974) and Hainau et al. (1977 showed means of 3.8,
3.0 and 4.9% respectively; again previous authors
do not distinguish between the differentiation
categories of these tumours.
Although we have directly compared our results
with these other reported series, the techniques
involved differ in that Muggia (1973) and Straus &
Moran (1977) used in vivo labelling Techniques,
whereas Livingston et al. (1974) used an in vitro
technique involving tumour cell suspensions
prepared from biopsy specimens; Hainau et al.
(1977) used small (1Omm3) tumour biopsies taken
from lungs of patients who had undergone
thoracotomy which were incubated with [3H]dT
under conditions of 5% CO2 in air rather than
hyperbaric oxygen. Our in vitro method involving a
representative tumour slice from resection
specimens, each of which was divided into small
1 mm3 fragments for in vitro labelling under
hyperbaric conditions, overcomes sampling
difficulties which arise when they are taken from
the frequently necrotic surface as well as handling
trauma to cells which occurs during preparation of
disaggregated tumour cell suspensions. We believe
the higher values for TLIs obtained in this study
reflect an improvement in the method of assessing
the TLI (vide infra).
The WP-L histological classification used, takes
into account the degree of differentiation of the 2
main groups (squamous and adenocarcinoma)
which have been shown to be related to prognosis
(Matthews, 1976). This grading of differentiation
takes into account the tissue differentiation, i.e. the
amount of squamous differentiation or of gland
formation, and does not relate to cytological
abnormality or mitotic activity.250 K.M. KERR, A.M.G. ROBERTSON & D. LAMB
We have also presented in this paper TLIs of a
unique series of less common and low grade
malignant tumours-carcinoids (4), adenoid cystic
(1), mucoepidermoid (1) and primary clear cell
carcinoma (1). These tumours all revealed low TLIs
which correlate with their less aggressive clinical
progression.
The mean value of 2.2% for the 3 secondary
renal carcinomata is in-keeping with the low values
obtained for primary well-differentiated
adenocarcinomata. The 2 secondary lesions from
the same lobe are of interest. Histologically they
were identical and in addition both showed an
intense inflammatory cell infiltrate. Independently-
estimated TLIs were closely correlated.
In this study we also found that labelling of
stromal cells and inflammatory cells varied greatly
from tumour to tumour though values were low
(< 3.5%); however, no correlation was found
between the TLIs of these components with either
the TLIs of tumour cells, or with the quantity of
stromal element and chronic inflammatory
infiltrate.
In vitro labelling of tumour fragments and counting
of TLI
In vitro [3H]dT labelling of tumour fragments is
improved under conditions of hyperbaric
oxygenation (Steel & Bensted, 1965; Fabrikant &
Wisseman, 1968; Denekamp & Kallman, 1973;
Meyer & Bauer, 1975). The cells in tissue fragments
must obtain oxygen by diffusion through the
medium from the gas phase in order to survive and
in particular for S-phase cells to utilise exogenous
[3H]dT. Johnson & Bond (1961) stated that with
pure oxygen at atmospheric pressure the depth at
which the oxygen concentration reaches zero in
human breast tissue is 230 pm. Thymidine
utilisation will occur only up to a depth short of
this zero point. The rationale behind using
hyperbaric oxygen is therefore to increase the depth
of [3H]dT utilisation and hopefully to overcome
the problems experienced by Johnson & Bond
(1961) and Lieb & Lisco (1966) where uptake of
label was only found in the superficial cells of
incubated tissue fragments. Fabrikant et al. (1969)
claimed that maximal depth of labelling could be
achieved using an oxygen pressure of 3
atmospheres; no improvement on labelling beyond
500,pm into the tissue could be obtained by raising
the oxygen pressure above 3 atmospheres. Meyer &
Connor (1977) claimed to confirm this.
Using hyperbaric oxygen at a pressure of 3
atmospheres, we only achieved a rim of labelling
around the edges of lung tumour fragments. The
rim effect appears to be the result of a metabolic
gradient of oxygen tension and diffusing
metabolites, where any change in these latter
components will affect the final rim depth. The
effect of changing oxygen tension has already been
mentioned and our early trials with the technique
confirmed deeper labelling when using hyperbaric
oxygen compared with 95% 02/5% CO2 at
atmospheric pressure. In some cases we incubated
tumour fragments with [3H]-uridine and labelling
occurred throughout all the fragments though a
decrease in labelling intensity towards their centre
was seen (data not shown). This suggests that the
metabolites do in fact diffuse throughout the tissue
fragments.
The availability of sufficient oxygen may
determine the degree of utilisation. Thus, tumour
cells utilising [3H]-uridine require less oxygen than
the S-phase tumour cells to take up and incorporate
exogenous [3H]dT. For a given oxygen
concentration and metabolite the rim depth
probably also depends on the particular cell type in
the tissue under study. We noted on several
occasions where stromal fibroblast labelling was
prominent in solid tumours that within the same
tumours and in identical fields counted, the D70 for
fibroblasts was considerably greater than that for
tumour cells. We also noted, during some
preliminary labelling studies using foetal rat liver,
that the D70 for more actively proliferating
haemopoietic cells was much less than that of the
hepatocytes.
Our rim of [3H]dT labelling varied in depth from
tumour to tumour and the D70 values calculated
suggested that the depth of labelling is inversely
proportional to the TLI and these 2 factors may be
exponentially related. A relationship between TLI
and depth has also been observed by Meyer &
Connor (1977) who referred to a steeper labelling
gradient in highly cellular tissues with high TLI
when compared with tissues of low cellularity and
TLI. The same workers noted a lower TLI in a
deeper zone of the tumour when compared with the
periphery. Chavaudra et al. (1979) also discuss the
variation of TLI with depth in labelling in tissue
fragments stating that in some squamous
carcinomata labelling is maximal between 21-40 um
and in others between 80-100pm deep.
The rim effect and its variability has further
implications concerning this type of work. Firstly, it
raises questions concerning experiments where
tissue is homogenised after incubation and the
radioactivity present detected by scintillation
counting. As labelling depends on the precursor
used, and since differences in TLI and D70 values
do exist between different cell populations in the
same tissue, the validity of such work (Sky-Peck,
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experience with lung tumours, even when
considering a single histological tumour group, one
cannot assume that tumour cells are consistent in
their behaviour under these experimental conditions
from case to case.
Secondly, the choice of which areas to consider
for counting TLI often seems quite arbitrary.
Meyer & Connor (1977), Chavaudra et al. (1979)
and others have commented that much of the
current data available on in vitro human tumour
[3H]dT labelling may underestimate tumour cell
TLIs since areas deep in the fragments with
suboptimal labelling are being counted. Hainau et
al. (1977) would score tumour cells in a field where
no labelled tumour cells were present if labelled
stroma was seen, this being taken as evidence of
adequate conditions for tumour cell labelling. What
has been presented and discussed above suggests
that this is not necessarily so. In our tumours with
a low labelling frequency, knowing the depth to
which labelling occurred we could assume adequate
conditions for counting along the entire fragment
edge even if the edge only contained one labelled
cell; one cannot omit counting peripheral zones like
these just because so few labelled cells are present
as this would falsely raise the TLI.
In some of our cases we questioned whether a
low TLI reflected technical difficulties involving
uptake of [3H]dT. However, the MI values do not
support this idea as the proportion of TLI:MI is
fairly constant with low values of TLI having
proportionally low values of MI. We feel our
method of "tailoring" as far as practicable, the
depth of our rim for counting from labelling
patterns on histograms for each tumour and then
counting all areas in that rim in each fragment edge
considered, overcomes many of these doubts and
gives optimum results for tumour cell TLI in the
fragment areas counted.
Data on human tumour cell kinetics is of interest
since it reflects one of the factors contributing
directly to the growth of the neoplasm. Such data
can be studied in conjunction with the in vivo
growth of the tumour in the patient.
Comparisons such as these depend on the fact
that the in vitro techniques of [3H]dT labelling are
reproducible and adequately reflect the in vivo
situation. Direct comparison of methodology has
been made by Johnson & Bond (1961) and
Denekamp & Kallman (1973) all of whom conclude
that in vitro systems can and do reflect the in vivo
state. This point is further discussed by Tubiana
(1971) and Steel (1977) with similar conclusions. In
particular, doubts may be raised concerning the
effects of transporting tumour tissue at 4°C prior to
incubation at 37°C. Several groups have
investigated the effect of this cold shock with direct
reference to [3H]dT labelling of tumours. Fabrikant
et al. (1969) and Steel & Bensted (1965) both found
that thymidine uptake was unchanged during
storage of tissue at 4°C for up to 6h, when
compared with tissue processed immediately. Mayer
& Bauer (1975) found that even storing tissue at
room temperature for up to 135 min made no
difference to labelling.
We hope it will also be possible, at a suitable
point in the future to follow-up the 57 patients and
determine whether the TLI has any relationship to
clinical progress taking into account histological cell
type and stage.
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